Cargando…

Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behaviour

Losartan potassium is an angiotensin II receptor antagonist readily absorbed from the GIT, following oral administration. It has low bioavailability as it undergoes extensive first pass metabolism and low elimination half-life. The present study was aimed at studying sustained release behaviour of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vohra, D. D., Pagi, K. S., Rajesh, K. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original/Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467813/ https://www.ncbi.nlm.nih.gov/pubmed/23066216 http://dx.doi.org/10.4103/0975-7406.94147

Ejemplares similares

Preparation and Characterization of Hydrophilic Polymer Based Sustained-Release Matrix Tablets of a High Dose Hydrophobic Drug
por: Khan, Niaz Ali, et al.
Publicado: (2022)

In vitro Evaluation of the Effect of Combination of Hydrophilic and Hydrophobic Polymers on Controlled Release Zidovudine Matrix Tablets
por: Ganesh, S., et al.
Publicado: (2008)

Role of various natural, synthetic and semi-synthetic polymers on drug release kinetics of losartan potassium oral controlled release tablets
por: Jayasree, J., et al.
Publicado: (2014)

Formulation and Evaluation of a Sustained-Release Tablets of Metformin Hydrochloride Using Hydrophilic Synthetic and Hydrophobic Natural Polymers
por: Wadher, K. J., et al.
Publicado: (2011)

Response Surface Optimization of Sustained Release Metformin-Hydrochloride Matrix Tablets: Influence of Some Hydrophillic Polymers on the Release
por: Roy, Amitava, et al.
Publicado: (2012)

Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
por: Bajpai, M., et al.
Publicado: (2012)

Study on sustained-release metformin hydrochloride from matrix tablet: Influence of hydrophilic polymers and in vitro evaluation
por: Wadher, Kamlesh J, et al.
Publicado: (2011)

Influence of Different Polymer Types on the Overall Release Mechanism in Hydrophilic Matrix Tablets
por: Körner, Anna, et al.
Publicado: (2009)

Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
por: Nardi-Ricart, Anna, et al.
Publicado: (2020)

Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets
por: Milanowski, Bartłomiej, et al.
Publicado: (2020)

Development and evaluation of chitosan based oral controlled matrix tablets of losartan potassium
por: Rao, Tallapaneni Vishnuvardhan, et al.
Publicado: (2012)

Controlled-Release Carbamazepine Matrix Granules and Tablets Comprising Lipophilic and Hydrophilic Components
por: Barakat, Nahla S., et al.
Publicado: (2009)

IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress
por: Mohylyuk, Valentyn, et al.
Publicado: (2020)

Comparative release profile of sustained release matrix tablets of verapamil HCl
por: Mathur, Vikas, et al.
Publicado: (2013)

Hydrophilic Natural Polymers for Sustained-controlled Release of Calcium Hydroxide
por: Farhadian, Negin, et al.
Publicado: (2020)

Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers
por: Roy, Harekrishna, et al.
Publicado: (2013)

Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression
por: Luo, Qiuhua, et al.
Publicado: (2022)

Statistical Optimization of Sustained Release Venlafaxine HCI Wax Matrix Tablet
por: Bhalekar, M. R., et al.
Publicado: (2008)

Sustained-release losartan from peptide nanofibers promotes chondrogenesis
por: Yamaura, Kohei, et al.
Publicado: (2023)

Controlled Release of Highly Hydrophilic Drugs from Novel Poly(Magnesium Acrylate) Matrix Tablets
por: Simancas-Herbada, Rebeca, et al.
Publicado: (2020)

Human Bioequivalence Evaluation of Two Losartan Potassium Tablets Under Fasting Conditions
por: Das, A. K., et al.
Publicado: (2015)

Formulation, evaluation and optimization of sustained release matrix tablets of captopril
por: Pandya, V. Pandya, et al.
Publicado: (2012)

Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays
por: Venkatesh, D. Nagasamy, et al.
Publicado: (2022)

The effect of alcohol on ionizing and non-ionizing drug release from hydrophilic, lipophilic and dual matrix tablets
por: Lochař, Václav, et al.
Publicado: (2020)

Effect of Quaternary Ammonium Carboxymethylchitosan on Release Rate In-vitro of Aspirin Sustained-release Matrix Tablets
por: Meng, Lingbin, et al.
Publicado: (2013)

Effect of Hydrophilic Diluents on the Release Profile of Griseofulvin from Tablet Formulations
por: Umeh, O. N. C., et al.
Publicado: (2013)

Effect of the Surface Hydrophobicity Degree on the In Vitro Release of Polar and Non-Polar Drugs from Polyelectrolyte Matrix Tablets
por: Yarce, Cristhian J., et al.
Publicado: (2018)

Spectrophotometric and HPLC Methods for Simultaneous Estimation of Amlodipine Besilate, Losartan Potassium and Hydrochlorothiazide in Tablets
por: Wankhede, S. B., et al.
Publicado: (2010)

Improvement of Drug Release and Compatibility between Hydrophilic Drugs and Hydrophobic Nanofibrous Composites
por: Haroosh, Hazim J., et al.
Publicado: (2021)

Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
por: Elezaj, Valentinë, et al.
Publicado: (2022)

Smart phase transformation system based on lyotropic liquid crystalline@hard capsules for sustained release of hydrophilic and hydrophobic drugs
por: Zhang, Xuejuan, et al.
Publicado: (2020)

Chitosan-Montmorillonite Polymer Composites: Formulation and Evaluation of Sustained Release Tablets of Aceclofenac
por: Thakur, Garima, et al.
Publicado: (2015)

Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
por: Phaechamud, T., et al.
Publicado: (2010)

Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents
por: Khan, Kamran Ahmad, et al.
Publicado: (2022)

Evaluation of Hydrophilic and Hydrophobic Silica Particles on the Release Kinetics of Essential Oil Pickering Emulsions
por: Li, Zhe, et al.
Publicado: (2022)

A Method for Content Uniformity Determination of Atenolol and Losartan Potassium in Combined Tablet Dosage Form
por: Shah, S. A., et al.
Publicado: (2010)

Polymer Tablet Matrix Systems for the Controlled Release of Dry Betula pendula Leaf Extract
por: Penkov, Dimitar, et al.
Publicado: (2023)

Design and Evaluation of Losartan Potassium Effervescent Floating Matrix Tablets: In Vivo X-ray Imaging and Pharmacokinetic Studies in Albino Rabbits
por: Rahamathulla, Mohamed, et al.
Publicado: (2021)

Development and bioequivalence study of potassium chloride extended release tablets
por: Le Thi, Thu Van, et al.
Publicado: (2018)

Hydrophobic Recovery of Plasma-Hydrophilized Polyethylene Terephthalate Polymers
por: Primc, Gregor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nffaqc92aghfbvrd4id2cpa0to